Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CervoMed (CRVO) FCF Margin (2023 - 2025)

CervoMed's FCF Margin history spans 7 years, with the latest figure at 2004.29% for Q3 2025.

  • For Q3 2025, FCF Margin fell 175402.0% year-over-year to 2004.29%; the TTM value through Sep 2025 reached 404.64%, down 29519.0%, while the annual FY2024 figure was 169.76%, 6549.0% down from the prior year.
  • FCF Margin for Q3 2025 was 2004.29% at CervoMed, down from 370.63% in the prior quarter.
  • Across five years, FCF Margin topped out at 60.65% in Q1 2024 and bottomed at 2004.29% in Q3 2025.
  • The 3-year median for FCF Margin is 114.06% (2023), against an average of 340.51%.
  • The largest annual shift saw FCF Margin surged 4712bps in 2024 before it tumbled -175402bps in 2025.
  • A 3-year view of FCF Margin shows it stood at 101.92% in 2023, then plummeted by -265bps to 372.38% in 2024, then crashed by -438bps to 2004.29% in 2025.
  • Per Business Quant, the three most recent readings for CRVO's FCF Margin are 2004.29% (Q3 2025), 370.63% (Q2 2025), and 203.1% (Q1 2025).